Voting Opens to Select the Winner of the 2011 IN Cell Analyzer Image Competition

GE HealthcareGE Healthcare Life Sciences announced that voting for the 2011 IN Cell Analyzer Image Competition is now open. Both scientists and the wider public are invited to choose their favourite from 30 shortlisted images submitted by researchers worldwide.

When making their selection, voters can consider the beauty of the image, their interest in the science behind it, or a combination of the two. The winning entrants from each region (Americas, Europe and Asia/Rest of World) will be invited to New York to see their images projected on NBC's high definition screen in Times Square.

Carmen Laethem, Aerie Pharmaceuticals, a previous winner and a judge on the 2011 shortlisting panel, said, "The images of cells that scientists produce every day on the IN Cell Analyzer can be captivatingly beautiful, some reminiscent of scenes from nature or even evoking the visual style of artists such as Jackson Pollock or Miró. Behind that beauty lies valuable data which enables researchers to, for example, better understand the mechanisms behind disease at the cellular level or conduct early screens for potential new therapies."

Dr Amr Abid, General Manager of Cell Technologies, GE Healthcare Life Sciences, said, "Once again, we have an exciting range of images from around the world. We're proud of how they showcase the capabilities of cellular imaging with our IN Cell Analyzer systems but also believe scientists should share the images with friends and family to inspire them with the beauty of cells and provide an accessible introduction to their own research."

To view the shortlisted images and vote for your favourite, please visit:
http://www.gelifesciences.com/incellcompetition

Related news articles:

About the 2011 IN Cell Analyzer Image Competition
The IN Cell Image Competition, supported by BioTechniques, celebrates the outstanding research enabled by the superior image quality that IN Cell Analyzer systems deliver. Voting starts on 7 November and continues online until mid-December. Attendees at two conferences (ASCB, December 3-7, USA and MBSJ, December 13-16, Japan) will also be invited to vote for their favourite. The votes will be combined to select 3 winners, one from each region (Americas, Europe, Asia/Rest of World). Details of the judging panel can be found here and full terms and conditions can be found here.

About GE Healthcare's IN Cell Analyzer system
IN Cell Analyzer automated high content cell imagers, IN Cell Investigator image analysis software and IN Cell Miner data management software combine to provide a system that represents a total solution for high content sub cellular analysis in research and drug discovery. High-performance hardware, powerful software, and expert instrument and applications support are harmonized to transform the cellular workflow.

IN Cell Analyzer 2000 is a highly flexible, lamp-based high-content imaging instrument impressively enabling for a wide range of assays and techniques. The latest addition to the IN Cell Analyzer family, IN Cell Analyzer 6000 is a high-end, laser based confocal imaging platform for the most demanding high-content assays and screens. Featuring a novel and proprietary optical system that incorporates an iris-like variable aperture design and next-generation sCMOS technology, IN Cell Analyzer 6000 balances speed and image quality for challenging and variable assays.

About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries.

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...